This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Williams, M. A. Articles by Luthy, D. A. Search for Related Content PubMed PubMed Citation Articles by Williams, M. A. Articles by Luthy, D. A. Pubmed/NCBI databases OMIM Substance via MeSH Medline Plus Health Information High Risk Pregnancy Pregnancy

Plasma Adiponectin Concentrations in Early Pregnancy and Subsequent Risk of Gestational Diabetes Mellitus

Center for Perinatal Studies (M.A.W., C.Q., M.M.-R., S.V., T.S.), Swedish Medical Center, Seattle, Washington 98122; Department of Epidemiology (M.A.W.), University of Washington, School of Public Health and Community Medicine, Seattle, Washington 98195; and Obstetrix Medical Group (D.A.L.), Seattle, Washington 98122

Address all correspondence and requests for reprints to: Dr. Michelle A. Williams, Center for Perinatal Studies (Suite 4 North), Swedish Medical Center, 747 Broadway, Seattle, Washington 98122. E-mail: mwilliam{at}u.washington.edu.

Low plasma adiponectin has been identified as a risk factor for type 2 diabetes. Our objective was to determine the extent to which low maternal plasma adiponectin is predictive of gestational diabetes mellitus (GDM), a condition that is biochemically and epidemiologically similar to type 2 diabetes. We used a prospective, nested case-control study design to compare maternal plasma adiponectin concentrations in 41 cases with 70 controls. Subjects were selected from a population of 968 women who provided blood samples in early pregnancy. Plasma adiponectin was determined using an ELISA. Adiponectin concentrations were statistically significantly lower in women with GDM than controls (4.4 vs. 8.1 µg/ml, P < 0.001). Approximately 73% of women with GDM, compared with 33% of controls, had adiponectin concentrations less than 6.4 µg/ml. After adjusting for confounding, women with adiponectin concentrations less than 6.4 µg/ml experienced a 4.6-fold increased risk of GDM, as compared with those with higher concentrations (95% confidence interval, 1.8–11.6). Our findings are consistent with other reports suggesting an association between hypoadiponectemia and risk of type 2 diabetes. Our findings extend the literature to include GDM. Studies designed to examine the effect of dietary and pharmacological mediators of adiponectin concentrations in pregnant and nonpregnant subjects are warranted.

This research was supported by an award from the National Institutes of Health, National Institute of Child Health and Human Development (HD-R01–32562).

Abbreviations: BMI, Body mass index; CI, confidence interval(s); GDM, gestational diabetes mellitus; OGTT, oral glucose tolerance tests; OR, odds ratio(s); PPAR, peroxisome proliferator-activated receptors.

This article has been cited by other articles:

				T. Sir-Petermann, B. Echiburu, M M. Maliqueo, N. Crisosto, F. Sanchez, C. Hitschfeld, M. Carcamo, P. Amigo, and F. Perez-Bravo Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome Hum. Reprod., July 1, 2007; 22(7): 1830 - 1836. [Abstract] [Full Text] [PDF]

				T. A. Buchanan, A. Xiang, S. L. Kjos, and R. Watanabe What Is Gestational Diabetes? Diabetes Care, July 1, 2007; 30(Supplement_2): S105 - S111. [Full Text] [PDF]

				L. A. Barbour, C. E. McCurdy, T. L. Hernandez, J. P. Kirwan, P. M. Catalano, and J. E. Friedman Cellular Mechanisms for Insulin Resistance in Normal Pregnancy and Gestational Diabetes Diabetes Care, July 1, 2007; 30(Supplement_2): S112 - S119. [Full Text] [PDF]

				C. Zhang, S. Liu, C. G. Solomon, and F. B. Hu Dietary Fiber Intake, Dietary Glycemic Load, and the Risk for Gestational Diabetes Mellitus Diabetes Care, October 1, 2006; 29(10): 2223 - 2230. [Abstract] [Full Text] [PDF]

				M. Lappas, K. Yee, M. Permezel, and G. E Rice Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies J. Endocrinol., September 1, 2005; 186(3): 457 - 465. [Abstract] [Full Text] [PDF]